TickerFacts.

Atara Biotherapeutics, Inc. (ATRA): Net Income

Annual figures by period end, from SEC filings.

$32.69M
Year ended 2025-12-31
-$16.69M
Trailing 12 months to 2026-06-30
2013-12-31: -$8.77M2014-12-31: -$28.01M2015-12-31: -$57.22M2016-12-31: -$79.05M2017-12-31: -$119.49M2018-12-31: -$230.70M2019-12-31: -$290.98M2020-12-31: -$306.62M2021-12-31: -$340.14M2022-12-31: -$228.30M2023-12-31: -$276.13M2024-12-31: -$85.40M2025-12-31: $32.69M$32.69M
2013-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$32.69Mn/m2026-03-16, From 2025-01-01
2024-12-31-$85.40Mn/m2026-03-16, From 2024-01-01
2023-12-31-$276.13Mn/m2025-03-07, From 2023-01-01
2022-12-31-$228.30Mn/m2024-03-28, From 2022-01-01
2021-12-31-$340.14Mn/m2023-02-08, From 2021-01-01
2020-12-31-$306.62Mn/m2023-02-08, From 2020-01-01
2019-12-31-$290.98Mn/m2022-02-28, From 2019-01-01
2018-12-31-$230.70Mn/m2021-03-01, From 2018-01-01
2017-12-31-$119.49Mn/m2020-02-27, From 2017-01-01
2016-12-31-$79.05Mn/m2019-02-26, From 2016-01-01
2015-12-31-$57.22Mn/m2018-02-27, From 2015-01-01
2014-12-31-$28.01Mn/m2017-03-09, From 2014-01-01
2013-12-31-$8.77Mn/a2016-03-04, From 2013-01-01

Net Income at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Atara Biotherapeutics, Inc. (ATRA)2025-12-31$32.69Mn/m
Monte Rosa Therapeutics, Inc. (GLUE)2025-12-31-$38.63Mn/m
Agenus Inc (AGEN)2025-12-31-$3.08Mn/m
ImmunityBio, Inc. (IBRX)2025-12-31-$351.40Mn/m
Century Therapeutics, Inc. (IPSC)2025-12-31-$9.58Mn/m
Beam Therapeutics Inc. (BEAM)2025-12-31-$79.99Mn/m
Sutro Biopharma, Inc. (STRO)2025-12-31-$191.09Mn/m
Ginkgo Bioworks Holdings, Inc. (DNA)2025-12-31-$312.76Mn/m
REGENXBIO Inc. (RGNX)2025-12-31-$193.88Mn/m

Compare ATRA, GLUE, AGEN, IBRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗